Skip to main content
Full access
Letter to the Editor
Published Online: 1 November 2004

Pregnancy and Antidepressant Counseling

To the Editor: It was with great interest that we read the article by Adele C. Viguera, M.D., et al. (1) published recently. These results confirm what we have been aware of for many years: that pregnant women are not being counseled appropriately concerning drug therapy and reproductive risks.
The Motherisk Program is a counseling service for pregnant and lactating women and their health professionals, in which evidenced-based information is given on the safety/risk of drugs, chemicals, radiation, and infectious diseases to almost 40,000 callers/year. We published a study documenting the experiences of 36 women who had abruptly discontinued antidepressants or benzodiazepines upon finding out they were pregnant (2). All of the women reported discontinuation for fear of teratogenic risk, and 28 (77%) discontinued on the advice of their physicians. Despite receiving reassuring counseling that it would be appropriate to continue their medication, only 22 (61%) chose to do so (2).
To determine why these decisions were made, we are now carrying out a study to enroll women who are planning pregnancy or are in the first trimester who are taking an antidepressant. Two control groups of women have also been enrolled in the study: women taking nonpsychiatric drugs 1) on a long-term basis and 2) on a short-term basis. Our hypotheses are that there is still a stigma surrounding mental illness and that women are more cautious about taking a psychiatric drug during pregnancy. We asked the same questions of all three groups. Our preliminary results are that after all three groups had been advised that it was appropriate to continue their medication during pregnancy, 15% of the antidepressant group compared to 3.8% of the chronic medication group and 1.2% of the short-term treatment group decided to discontinue their drug. What we also found was that many factors come into play in the perception of teratogenic risk; however, in the determinants of decision making, the most important factor was the order in which the information was given to them, with the initial information having the most lasting effect (3).
We are sharing this information because we feel that it is an important area of research to ensure that women who are suffering from a mental illness are appropriately treated during pregnancy to ensure optimum conditions for both mother and child.

References

1.
Viguera AC, Cohen LS, Bouffard S, Whitfield TH, Baldessarini RJ: Reproductive decisions by women with bipolar disorder after prepregnancy psychiatric consultation. Am J Psychiatry 2002; 159:2102–2104
2.
Einarson A, Selby P, Koren G: Abrupt discontinuation of psychotropic drugs due to fears of teratogenic risk and the impact of counseling. J Psychiatry Neurosci 2001; 26:44–48
3.
Bonari L, Einarson A, Jasper JD, Einarson TR, Koren G: Determinants of women’s decision making regarding the use of antidepressants prior to and during pregnancy, in Abstracts of the 2002 Canadian Psychiatric Association Annual Meeting. Ottawa, CPA, 2002

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 2137
PubMed: 15514430

History

Published online: 1 November 2004
Published in print: November 2004

Authors

Affiliations

ADRIENNE EINARSON, R.N.
GIDEON KOREN, M.D.
Toronto, Ont., Canada

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share